Dihydroartemisinin inhibits the tumorigenesis and invasion of gastric cancer by regulating STAT1/KDR/MMP9 and P53/BCL2L1/CASP3/7 pathways
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Dihydroartemisinin inhibits the tumorigenesis and invasion of gastric cancer by regulating STAT1/KDR/MMP9 and P53/BCL2L1/CASP3/7 pathways
Authors
Keywords
Dihydroartemisinin, Gastric cancer, Network pharmacology, Bioinformatics analysis, Proliferation, Invasion
Journal
PATHOLOGY RESEARCH AND PRACTICE
Volume 218, Issue -, Pages 153318
Publisher
Elsevier BV
Online
2020-12-13
DOI
10.1016/j.prp.2020.153318
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Dihydroartemisinin Induces Growth Arrest and Overcomes Dexamethasone Resistance in Multiple Myeloma
- (2020) Ying Chen et al. Frontiers in Oncology
- Artemisinin and its derivatives prevent Helicobacter pylori-induced gastric carcinogenesis via inhibition of NF-κB signaling
- (2019) Tao Su et al. PHYTOMEDICINE
- The Effect of Dihydroartemisinin on the Malignancy and Epithelial–Mesenchymal Transition of Gastric Cancer Cells
- (2019) Nan Li et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- Network pharmacology-based identification of the protective mechanisms of taraxasterol in experimental colitis
- (2019) Wei Chen et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Dihydroartemisinin Regulates the Th/Treg Balance by Inducing Activated CD4+ T cell Apoptosis via Heme Oxygenase-1 Induction in Mouse Models of Inflammatory Bowel Disease
- (2019) Si Chao Yan et al. MOLECULES
- miR-150-5p represses TP53 tumor suppressor gene to promote proliferation of colon adenocarcinoma
- (2019) Fang Liu et al. Scientific Reports
- Multiscale Network Analysis Reveals Molecular Mechanisms and Key Regulators of the Tumor Microenvironment in Gastric Cancer
- (2019) Won‐Min Song et al. INTERNATIONAL JOURNAL OF CANCER
- Dihydroartemisinin inhibits the growth and invasion of gastric cancer cells by regulating cyclin D1-CDK4-Rb signaling
- (2019) Hui-Ning Fan et al. PATHOLOGY RESEARCH AND PRACTICE
- p27 allosterically activates cyclin-dependent kinase 4 and antagonizes palbociclib inhibition
- (2019) Keelan Z. Guiley et al. SCIENCE
- Computational chemical biology and drug design: Facilitating protein structure, function, and modulation studies
- (2018) Mingyue Zheng et al. MEDICINAL RESEARCH REVIEWS
- STAT3 activation confers trastuzumab-emtansine (T-DM1) resistance in HER2-positive breast cancer
- (2018) Lei Wang et al. CANCER SCIENCE
- A peptide mimicking the binding sites of VEGF-A and VEGF-B inhibits VEGFR-1/-2 driven angiogenesis, tumor growth and metastasis
- (2018) Maryam Farzaneh Behelgardi et al. Scientific Reports
- LncRNA AK023391 promotes tumorigenesis and invasion of gastric cancer through activation of the PI3K/Akt signaling pathway
- (2017) Yanxia Huang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Dihydroartemisinin Exerts Anti-Tumor Activity by Inducing Mitochondrion and Endoplasmic Reticulum Apoptosis and Autophagic Cell Death in Human Glioblastoma Cells
- (2017) Chengbin Qu et al. Frontiers in Cellular Neuroscience
- Comprehensive analyses of somatic TP53 mutation in tumors with variable mutant allele frequency
- (2017) Alexander J. Cole et al. Scientific Data
- Dihydroartemisinin selectively inhibits PDGFRα-positive ovarian cancer growth and metastasis through inducing degradation of PDGFRα protein
- (2017) Xiaoguang Li et al. Cell Discovery
- Structure Based docking studies towards exploring potential anti-androgen activity of selected phytochemicals against Prostate Cancer
- (2017) Anshika N. Singh et al. Scientific Reports
- Dihydroartemisinin induces apoptosis in human gastric cancer cell line BGC-823 through activation of JNK1/2 and p38 MAPK signaling pathways
- (2016) Shuyi Zhang et al. JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION
- CytoNCA: A cytoscape plugin for centrality analysis and evaluation of protein interaction networks
- (2015) Yu Tang et al. BIOSYSTEMS
- limma powers differential expression analyses for RNA-sequencing and microarray studies
- (2015) Matthew E. Ritchie et al. NUCLEIC ACIDS RESEARCH
- The Global Burden of Cancer 2013
- (2015) Christina Fitzmaurice et al. JAMA Oncology
- Old, new and emerging functions of caspases
- (2014) S Shalini et al. CELL DEATH AND DIFFERENTIATION
- Facilitating the use of large-scale biological data and tools in the era of translational bioinformatics
- (2013) I. Kouskoumvekaki et al. BRIEFINGS IN BIOINFORMATICS
- Stability and antiviral activity against human cytomegalovirus of artemisinin derivatives
- (2013) A. Flobinus et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Design, Synthesis and Evaluation of the Antibacterial Enhancement Activities of Amino Dihydroartemisinin Derivatives
- (2013) Chong Wu et al. MOLECULES
- Novel function of STAT1 in breast cancer
- (2013) Ming Zhang OncoImmunology
- Tumor Suppression by p53: Fall of the Triumvirate?
- (2012) Andreas K. Hock et al. CELL
- Dihydroartemisinin inhibits angiogenesis in pancreatic cancer by targeting the NF-κB pathway
- (2011) Shuang-Jia Wang et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Safety and pharmacokinetics of novel selective vascular endothelial growth factor receptor-2 inhibitor YN968D1 in patients with advanced malignancies
- (2010) Jin Li et al. BMC CANCER
- Tumor-promoting role of signal transducer and activator of transcription (Stat)1 in late-stage melanoma growth
- (2010) Julia Schultz et al. CLINICAL & EXPERIMENTAL METASTASIS
- The anti-cancer activity of dihydroartemisinin is associated with induction of iron-dependent endoplasmic reticulum stress in colorectal carcinoma HCT116 cells
- (2010) Jin-Jian Lu et al. INVESTIGATIONAL NEW DRUGS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More